These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 25851544)
21. The tumorigenic potential of pluripotent stem cells: What can we do to minimize it? Peterson SE; Garitaonandia I; Loring JF Bioessays; 2016 Jul; 38 Suppl 1():S86-95. PubMed ID: 27417126 [TBL] [Abstract][Full Text] [Related]
22. Transforming the promise of pluripotent stem cell-derived cardiomyocytes to a therapy: challenges and solutions for clinical trials. Prowse AB; Timmins NE; Yau TM; Li RK; Weisel RD; Keller G; Zandstra PW Can J Cardiol; 2014 Nov; 30(11):1335-49. PubMed ID: 25442434 [TBL] [Abstract][Full Text] [Related]
23. The use of human pluripotent stem cells for the in vitro derivation of cranial placodes and neural crest cells. Borchin BE; Barberi T Curr Top Dev Biol; 2015; 111():497-514. PubMed ID: 25662270 [TBL] [Abstract][Full Text] [Related]
24. Generating cells of the gastrointestinal system: current approaches and applications for the differentiation of human pluripotent stem cells. Wang A; Sander M J Mol Med (Berl); 2012 Jul; 90(7):763-71. PubMed ID: 22714642 [TBL] [Abstract][Full Text] [Related]
25. Advances in the Differentiation of Retinal Ganglion Cells from Human Pluripotent Stem Cells. Ohlemacher SK; Langer KB; Fligor CM; Feder EM; Edler MC; Meyer JS Adv Exp Med Biol; 2019; 1186():121-140. PubMed ID: 31654388 [TBL] [Abstract][Full Text] [Related]
26. Porous membrane culture method for expansion of human pluripotent stem cells. Kim JS; Hwang ST; Lee SH Methods Mol Biol; 2015; 1212():65-72. PubMed ID: 25556655 [TBL] [Abstract][Full Text] [Related]
27. Tumorigenicity studies for human pluripotent stem cell-derived products. Kuroda T; Yasuda S; Sato Y Biol Pharm Bull; 2013; 36(2):189-92. PubMed ID: 23370350 [TBL] [Abstract][Full Text] [Related]
28. Directed differentiation of human pluripotent stem cells along the pancreatic endocrine lineage. Van Hoof D; Liku ME Methods Mol Biol; 2013; 997():127-40. PubMed ID: 23546752 [TBL] [Abstract][Full Text] [Related]
30. Induced pluripotent stem cells: characteristics and perspectives. Cantz T; Martin U Adv Biochem Eng Biotechnol; 2010; 123():107-26. PubMed ID: 20549467 [TBL] [Abstract][Full Text] [Related]
31. Ultrasensitive and rapid quantification of rare tumorigenic stem cells in hPSC-derived cardiomyocyte populations. Wang Z; Gagliardi M; Mohamadi RM; Ahmed SU; Labib M; Zhang L; Popescu S; Zhou Y; Sargent EH; Keller GM; Kelley SO Sci Adv; 2020 Mar; 6(12):eaay7629. PubMed ID: 32440533 [TBL] [Abstract][Full Text] [Related]
32. Stencil Micropatterning of Human Pluripotent Stem Cells for Probing Spatial Organization of Differentiation Fates. Sahni G; Yuan J; Toh YC J Vis Exp; 2016 Jun; (112):. PubMed ID: 27340925 [TBL] [Abstract][Full Text] [Related]
33. Synthetic probes for in vitro purification and in vivo tracking of hepatocytes derived from human pluripotent stem cells. Park JY; Han J; Jung HS; Lee G; Kim HJ; Cho GS; Park HJ; Han C; Kim JS; Kim JH Biomaterials; 2019 Nov; 222():119431. PubMed ID: 31450160 [TBL] [Abstract][Full Text] [Related]
34. Nanotopography regulates motor neuron differentiation of human pluripotent stem cells. Chen W; Han S; Qian W; Weng S; Yang H; Sun Y; Villa-Diaz LG; Krebsbach PH; Fu J Nanoscale; 2018 Feb; 10(7):3556-3565. PubMed ID: 29410983 [TBL] [Abstract][Full Text] [Related]
35. Human pluripotent stem cell-derived products: advances towards robust, scalable and cost-effective manufacturing strategies. Jenkins MJ; Farid SS Biotechnol J; 2015 Jan; 10(1):83-95. PubMed ID: 25524780 [TBL] [Abstract][Full Text] [Related]
36. Technical approaches to induce selective cell death of pluripotent stem cells. Jeong HC; Cho SJ; Lee MO; Cha HJ Cell Mol Life Sci; 2017 Jul; 74(14):2601-2611. PubMed ID: 28246701 [TBL] [Abstract][Full Text] [Related]
37. Directed differentiation of pluripotent stem cells: from developmental biology to therapeutic applications. Irion S; Nostro MC; Kattman SJ; Keller GM Cold Spring Harb Symp Quant Biol; 2008; 73():101-10. PubMed ID: 19329573 [TBL] [Abstract][Full Text] [Related]
39. Enabling consistency in pluripotent stem cell-derived products for research and development and clinical applications through material standards. French A; Bravery C; Smith J; Chandra A; Archibald P; Gold JD; Artzi N; Kim HW; Barker RW; Meissner A; Wu JC; Knowles JC; Williams D; García-Cardeña G; Sipp D; Oh S; Loring JF; Rao MS; Reeve B; Wall I; Carr AJ; Bure K; Stacey G; Karp JM; Snyder EY; Brindley DA Stem Cells Transl Med; 2015 Mar; 4(3):217-23. PubMed ID: 25650438 [TBL] [Abstract][Full Text] [Related]
40. Multisite studies for validation and improvement of a highly efficient culture assay for detection of undifferentiated human pluripotent stem cells intermingled in cell therapy products. Watanabe T; Yasuda S; Kusakawa S; Kuroda T; Futamura M; Ogawa M; Mochizuki H; Kikkawa E; Furukawa H; Nagaoka M; Sato Y Cytotherapy; 2021 Feb; 23(2):176-183. PubMed ID: 32978066 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]